CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy

Rationale: An antibody-drug conjugate (ADC) is a targeted therapy consisting of a cytotoxic payload that is linked to an antibody which targets a protein enriched on malignant cells. Multiple ADCs are currently used clinically as anti-cancer agents significantly improving patient survival. Herein, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Tashbib, Lyons, Nicholas J., Gough, Madeline, Kwah, Kayden K.X., Cuda, Tahleesa J., Snell, Cameron E., Tse, Brian W., Sokolowski, Kamil A., Pearce, Lesley A., Adams, Timothy E., Rose, Stephen E., Puttick, Simon, Pajic, Marina, Adams, Mark N., He, Yaowu, Hooper, John D., Kryza, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576610/
https://www.ncbi.nlm.nih.gov/pubmed/36276654
http://dx.doi.org/10.7150/thno.78171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576610/
https://www.ncbi.nlm.nih.gov/pubmed/36276654
http://dx.doi.org/10.7150/thno.78171

Ejemplares similares